Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Double-Scan strategy could sharpen prostate cancer staging

NCT ID NCT07455097

First seen Mar 07, 2026 · Last updated May 19, 2026 · Updated 9 times

Summary

This study looks at whether combining PSMA-PET/CT and MRI scans can more accurately determine the extent of prostate cancer in men with intermediate- or high-risk disease. Researchers will compare the scans to the actual tissue removed during surgery in 600 men across European centers. The goal is to improve staging and guide personalized treatment, such as which lymph nodes to remove and how much nerve tissue to spare.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIGH-RISK PROSTATE CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Fortis Hospital

    Kolkata, India

  • KU Leuven

    Leuven, Belgium

  • Ludwig-Maximilians-University Munich

    Munich, Germany

  • Lund University Hospital

    Lund, Sweden

  • Marienhospital Herne

    Herne, Germany

  • Medical University Vienna

    Vienna, Austria

  • San Raffaele University Hospital Milan

    Milan, Italy

  • University Hospital Bern

    Bern, Switzerland

  • University Hospital Düsseldorf

    Düsseldorf, 40225, Germany

  • University Hospital Tübingen

    Tübingen, Germany

Conditions

Explore the condition pages connected to this study.